Literature DB >> 24866878

Preimplantation genetic diagnosis for inherited neurological disorders.

Ilan Tur-Kaspa1, Roohi Jeelani2, P Murali Doraiswamy3.   

Abstract

Preimplantation genetic diagnosis (PGD) is an option for couples at risk of having offspring with an inherited debilitating or fatal neurological disorder who wish to conceive a healthy child. PGD has been carried out for conditions with various modes of inheritance, including spinal muscular atrophy, Huntington disease, fragile X syndrome, and chromosomal or mitochondrial disorders, and for susceptibility genes for cancers with nervous system involvement. Most couples at risk of transmitting a genetic mutation would opt for PGD over prenatal testing and possible termination of a pregnancy. The aim of this Perspectives article is to assist neurologists in counselling and treating patients who wish to explore the option of PGD to enable conception of an unaffected child. PGD can be accomplished for most disorders in which the genetic basis is known, and we argue that it is time for clinicians and neurological societies to consider the evidence and to formulate guidelines for the responsible integration of PGD into modern preventative neurology.

Entities:  

Mesh:

Year:  2014        PMID: 24866878     DOI: 10.1038/nrneurol.2014.84

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  81 in total

1.  Single embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate.

Authors:  P Donoso; W Verpoest; E G Papanikolaou; I Liebaers; H M Fatemi; K Sermon; C Staessen; J Van der Elst; P Devroey
Journal:  Hum Reprod       Date:  2007-01-04       Impact factor: 6.918

2.  Clinical application of comprehensive chromosomal screening at the blastocyst stage.

Authors:  William B Schoolcraft; Elpida Fragouli; John Stevens; Santiago Munne; Mandy G Katz-Jaffe; Dagan Wells
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

Review 3.  The ESHRE PGD Consortium: 10 years of data collection.

Authors:  J C Harper; L Wilton; J Traeger-Synodinos; V Goossens; C Moutou; S B SenGupta; T Pehlivan Budak; P Renwick; M De Rycke; J P M Geraedts; G Harton
Journal:  Hum Reprod Update       Date:  2012-02-16       Impact factor: 15.610

4.  The case for a parental duty to use preimplantation genetic diagnosis for medical benefit.

Authors:  Janet Malek; Judith Daar
Journal:  Am J Bioeth       Date:  2012       Impact factor: 11.229

5.  Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

Authors:  Sesh Kamal Sunkara; Vivian Rittenberg; Nick Raine-Fenning; Siladitya Bhattacharya; Javier Zamora; Arri Coomarasamy
Journal:  Hum Reprod       Date:  2011-05-10       Impact factor: 6.918

6.  Seven years of experience of preimplantation HLA typing: a clinical overview of 327 cycles.

Authors:  Semra Kahraman; Cagri Beyazyurek; Cumhur Gokhan Ekmekci
Journal:  Reprod Biomed Online       Date:  2011-06-15       Impact factor: 3.828

7.  Preimplantation genetic diagnosis with HLA matching.

Authors:  Svetlana Rechitsky; Anver Kuliev; Illan Tur-Kaspa; Randy Morris; Yury Verlinsky
Journal:  Reprod Biomed Online       Date:  2004-08       Impact factor: 3.828

8.  Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease.

Authors:  Nathan R Treff; Anastasia Fedick; Xin Tao; Batsal Devkota; Deanne Taylor; Richard T Scott
Journal:  Fertil Steril       Date:  2013-01-09       Impact factor: 7.329

Review 9.  Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections.

Authors:  C E M de Die-Smulders; G M W R de Wert; I Liebaers; A Tibben; G Evers-Kiebooms
Journal:  Hum Reprod Update       Date:  2013-02-01       Impact factor: 15.610

10.  ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening.

Authors:  G Harton; P Braude; A Lashwood; A Schmutzler; J Traeger-Synodinos; L Wilton; J C Harper
Journal:  Hum Reprod       Date:  2010-10-21       Impact factor: 6.918

View more
  6 in total

Review 1.  Current concepts in the treatment of hereditary ataxias.

Authors:  Pedro Braga Neto; José Luiz Pedroso; Sheng-Han Kuo; C França Marcondes Junior; Hélio Afonso Ghizoni Teive; Orlando Graziani Povoas Barsottini
Journal:  Arq Neuropsiquiatr       Date:  2016-03       Impact factor: 1.420

2.  First successful trial of preimplantation genetic diagnosis for pantothenate kinase-associated neurodegeneration.

Authors:  Objoon Trachoo; Chonthicha Satirapod; Bhakbhoom Panthan; Matchuporn Sukprasert; Angkana Charoenyingwattana; Wasun Chantratita; Wicharn Choktanasiri; Suradej Hongeng
Journal:  J Assist Reprod Genet       Date:  2016-11-04       Impact factor: 3.412

Review 3.  Current molecular insight to reveal the dynamics of CAG repeating units in spinocerebellar ataxia.

Authors:  Priyanka Vishwakarma; Srinivasan Muthuswamy; Sarita Agarwal
Journal:  Intractable Rare Dis Res       Date:  2018-05

4.  In vitro fertilisation with preimplantation genetic testing: the need for expanded insurance coverage.

Authors:  Madison K Kilbride
Journal:  J Med Ethics       Date:  2020-08-19       Impact factor: 2.903

5.  Spinocerebellar Ataxia Patient Perceptions Regarding Reproductive Options.

Authors:  Suzanne Cahn; Ami Rosen; George Wilmot
Journal:  Mov Disord Clin Pract       Date:  2019-11-25

Review 6.  Towards Personalized Intervention for Alzheimer's Disease.

Authors:  Xing Peng; Peiqi Xing; Xiuhui Li; Ying Qian; Fuhai Song; Zhouxian Bai; Guangchun Han; Hongxing Lei
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-09-28       Impact factor: 7.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.